Discrepancy between the European clinical guidelines and myocardial revascularization in patients with stable coronary artery disease in Russia

被引:1
|
作者
Kiselev, Anton R. [1 ]
Korotin, Alexey S. [1 ]
Posnenkova, Olga M. [1 ]
Popova, Yulia V. [1 ]
Prokhorov, Mikhail D. [2 ]
Gridnev, Vladimir I. [1 ]
机构
[1] Saratov State Med Univ, Dept New Cardiol Informat Technol, Res Inst Cardiol, 112 Bolshaya Kazachya Str, Saratov 410012, Russia
[2] Russian Acad Sci, Saratov Branch, Lab Nonlinear Dynam Modelling, Inst Radio Engn & Elect, Saratov 410019, Russia
关键词
coronary artery disease; myocardial revascularization; ESC; EACTS guidelines; clinical indications; OPTIMAL MEDICAL THERAPY; ISCHEMIC-HEART-DISEASE; BYPASS GRAFT-SURGERY; INTERVENTION; MANAGEMENT; LIFE; PCI;
D O I
10.1093/intqhc/mzy140
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
In European Society of Cardiology/European Association for Cardio-Thoracic Surgery (ESC/EACTS) guidelines, six indications have been proposed for making a decision on myocardial revascularization in patients with stable coronary artery disease (CAD). Our aim was to study a discrepancy between the actual clinical situation and ESC/EACTS indications on performing the revascularization in patients with CAD in Russia. We used retrospective clinical data on patients with stable CAD enrolled in the 20122015 Russian Registry of Hypertension, Coronary Artery Disease, and Chronic Heart Failure. A total of 1522 patients with CAD (aged 53.0 8.5 years, 76.2% male) were used for analysis. All patients were divided into two groups: 591 patients with performed myocardial revascularization (named as R-CAD) and 931 patients refused from revascularization (named as NR-CAD). Factors associated with revascularization performance were identified by discriminant function analysis. ESC/EACTS indications for revascularization were assessed. A total of 1196 patients with CAD had any ESC/EACTS indication for revascularization, but only 40.2% of them had performed invasive coronary intervention. Myocardial revascularization was appropriate in 81.4% of R-CAD patients and 76.8% of NR-CAD patients. The main factor of revascularization performance was any stenosis > 50% and grades IIIIV of stable angina. With non-performed revascularization, the following factors were associated: limiting angina or angina equivalent, unresponsive to medical therapy, atherosclerotic peripheral arterial disease and increasing the New York Heart Association class of chronic heart failure. Most ESC/EACTS indications had little effect on decision-making on revascularization. There is a discrepancy between the actual clinical situation and ESC/EACTS guidelines on myocardial revascularization in patients with stable CAD in Russia.
引用
收藏
页码:269 / 275
页数:7
相关论文
共 50 条
  • [11] Revascularization in stable coronary artery disease
    Al-Lamee, Rasha K.
    Foley, Michael
    Rajkumar, Christopher A.
    Francis, Darrel P.
    BMJ-BRITISH MEDICAL JOURNAL, 2022, 377
  • [12] Implications of new ESC/EACTS guidelines on myocardial revascularization for patients with multivessel coronary artery disease
    Ribichini, Flavio
    Taggart, David
    INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2011, 12 (05) : 663 - 666
  • [13] Coronary Revascularization in Patients With Stable Coronary Artery Disease: The Role of Imaging
    Neglia, Danilo
    Maroz-Vadalazhskaya, Natallia
    Carrabba, Nazario
    Liga, Riccardo
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [14] MYOCARDIAL REVASCULARIZATION FOR CORONARY ARTERY DISEASE
    BAUE, AE
    JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1970, 213 (01): : 135 - &
  • [15] The effect of revascularization on outcomes of patients with stable coronary artery disease
    Jeremias, Allen
    Gruberg, Luis
    Rosengart, Todd K.
    Brown, David L.
    CIRCULATION, 2007, 116 (16) : 538 - 538
  • [16] The Association of Guideline Adherence of Coronary Revascularization and Clinical Outcomes for Patients With Stable and Complex Coronary Artery Disease
    Rao, Chenfei
    Zheng, Zhe
    Hu, Shengshou
    Zhang, Heng
    CIRCULATION, 2015, 132
  • [17] The adequacy of myocardial revascularization in patients with multivessel coronary artery disease
    Zimarino, Marco
    Curzen, Nick
    Cicchitti, Vincenzo
    De Caterina, Raffaele
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 168 (03) : 1748 - 1757
  • [18] Revascularization in advanced stable coronary artery disease
    Gutstein, DE
    Fuster, V
    DRUGS OF TODAY, 1998, 34 (01) : 37 - 44
  • [19] Revascularization treatment of stable coronary artery disease
    Magro, Michael
    Garg, Scot
    Serruys, Patrick W.
    EXPERT OPINION ON PHARMACOTHERAPY, 2011, 12 (02) : 195 - 212
  • [20] Management of Myocardial Revascularization in Patients With Stable Coronary Artery Disease Undergoing Transcatheter Aortic Valve Implantation
    Costa, Giuliano
    Pilgrim, Thomas
    Santos, Ignacio J. Amat
    De Backer, Ole
    Kim, Won-Keun
    Ribeiro, Henrique Barbosa
    Saia, Francesco
    Bunc, Matjaz
    Tchetche, Didier
    Garot, Philippe
    Ribichini, Flavio Luciano
    Mylotte, Darren
    Burzotta, Francesco
    Watanabe, Yusuke
    De Marco, Federico
    Tesorio, Tullio
    Rheude, Tobias
    Tocci, Marco
    Franzone, Anna
    Valvo, Roberto
    Savontaus, Mikko
    Wienemann, Hendrik
    Porto, Italo
    Gandolfo, Caterina
    Iadanza, Alessandro
    Santo Bortone, Alessandro
    Mach, Markus
    Latib, Azeem
    Biasco, Luigi
    Taramasso, Maurizio
    Zimarino, Marco
    Tomii, Daijiro
    Nuyens, Philippe
    Sondergaard, Lars
    Camara, Sergio F.
    Palmerini, Tullio
    Orzalkiewicz, Mateusz
    Steblovnik, Klemen
    Degrelle, Bastien
    Gautier, Alexandre
    Del Sole, Paolo Alberto
    Mainardi, Andrea
    Pighi, Michele
    Lunardi, Mattia
    Kawashima, Hideyuki
    Criscione, Enrico
    Cesario, Vincenzo
    Biancari, Fausto
    Zanin, Federico
    Joner, Michael
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2022, 15 (12) : 950 - 962